BR9305946A - Tratamento de condições auto-imunes de longo termo - Google Patents

Tratamento de condições auto-imunes de longo termo

Info

Publication number
BR9305946A
BR9305946A BR9305946A BR9305946A BR9305946A BR 9305946 A BR9305946 A BR 9305946A BR 9305946 A BR9305946 A BR 9305946A BR 9305946 A BR9305946 A BR 9305946A BR 9305946 A BR9305946 A BR 9305946A
Authority
BR
Brazil
Prior art keywords
treatment
long
autoimmune conditions
term autoimmune
immunologically mediated
Prior art date
Application number
BR9305946A
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College filed Critical Univ College
Publication of BR9305946A publication Critical patent/BR9305946A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9305946A 1992-02-21 1993-02-19 Tratamento de condições auto-imunes de longo termo BR9305946A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions
PCT/GB1993/000351 WO1993016727A1 (en) 1992-02-21 1993-02-19 Mycobacterium vaccae for treatment of long term autoimmune conditions

Publications (1)

Publication Number Publication Date
BR9305946A true BR9305946A (pt) 1997-10-21

Family

ID=10710862

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9305946A BR9305946A (pt) 1992-02-21 1993-02-19 Tratamento de condições auto-imunes de longo termo

Country Status (24)

Country Link
US (1) US5885588A (pt)
EP (2) EP0763361B1 (pt)
JP (1) JPH07506093A (pt)
KR (1) KR100275862B1 (pt)
AT (2) ATE151641T1 (pt)
AU (2) AU675421B2 (pt)
BG (1) BG99054A (pt)
BR (1) BR9305946A (pt)
CA (1) CA2130117A1 (pt)
CZ (1) CZ282651B6 (pt)
DE (2) DE69328503T2 (pt)
DK (2) DK0630259T3 (pt)
ES (2) ES2104131T3 (pt)
FI (1) FI943849A0 (pt)
GB (1) GB9203814D0 (pt)
GR (2) GR3024113T3 (pt)
HU (1) HU218347B (pt)
NO (1) NO311169B1 (pt)
NZ (1) NZ249518A (pt)
RO (1) RO117833B1 (pt)
RU (1) RU2124367C1 (pt)
SK (1) SK99994A3 (pt)
UA (1) UA35583C2 (pt)
WO (1) WO1993016727A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU730548B2 (en) * 1996-12-18 2001-03-08 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the TH2 activity of the immune system
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
EP1044273A2 (en) * 1997-12-23 2000-10-18 Genesis Research & Development Corporation Limited COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
WO2001010221A1 (en) * 1999-08-06 2001-02-15 Corixa Corporation Vaccines for the treatment of autoimmune disease
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
WO2005049056A2 (en) * 2003-11-14 2005-06-02 Ucl Biomedica Plc Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
CA2095855C (en) * 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens

Also Published As

Publication number Publication date
NZ249518A (en) 1997-07-27
DE69328503T2 (de) 2000-08-24
DE69328503D1 (de) 2000-05-31
FI943849A0 (fi) 1994-08-22
AU7188796A (en) 1997-02-06
KR100275862B1 (ko) 2000-12-15
EP0630259B1 (en) 1997-04-16
AU3637793A (en) 1993-09-13
CZ282651B6 (cs) 1997-08-13
NO943082L (no) 1994-10-17
EP0763361A2 (en) 1997-03-19
WO1993016727A1 (en) 1993-09-02
RO117833B1 (ro) 2002-08-30
DK0630259T3 (da) 1997-09-15
ATE151641T1 (de) 1997-05-15
HUT69941A (en) 1995-09-28
AU675421B2 (en) 1997-02-06
HU9402422D0 (en) 1994-10-28
GR3024113T3 (en) 1997-10-31
US5885588A (en) 1999-03-23
EP0630259A1 (en) 1994-12-28
NO311169B1 (no) 2001-10-22
BG99054A (en) 1995-08-28
GR3033772T3 (en) 2000-10-31
DE69309915D1 (de) 1997-05-22
CZ202394A3 (en) 1995-02-15
RU2124367C1 (ru) 1999-01-10
HU218347B (hu) 2000-08-28
GB9203814D0 (en) 1992-04-08
SK99994A3 (en) 1995-05-10
AU706122B2 (en) 1999-06-10
ES2104131T3 (es) 1997-10-01
RU94045825A (ru) 1997-02-20
DK0763361T3 (da) 2000-08-07
EP0763361A3 (en) 1997-03-26
EP0763361B1 (en) 2000-04-26
UA35583C2 (uk) 2001-04-16
DE69309915T2 (de) 1997-07-24
ATE192046T1 (de) 2000-05-15
CA2130117A1 (en) 1993-09-02
NO943082D0 (no) 1994-08-22
KR950700755A (ko) 1995-02-20
JPH07506093A (ja) 1995-07-06
ES2145968T3 (es) 2000-07-16

Similar Documents

Publication Publication Date Title
BR9305946A (pt) Tratamento de condições auto-imunes de longo termo
GR3018652T3 (en) Mycobacterium vaccae in the treatment of uveitis
EP0537191A4 (en) Treatment of organ transplantation rejection
ATE98125T1 (de) Zusammensetzungen essentieller fettsaeuren und therapie.
GB8319073D0 (en) Fatty acid compositions
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
EP0413329A3 (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
FI931451A7 (fi) 7-okso-7H-pyrido(1,2,3-de)(1,4)bentsoksatsiini-6-karboksyylihapot ja -esterit
DE3884241D1 (de) Analoge des Porcin-Wachstumshormones.
GB1543326A (en) Appliance for immobilising and/or supporting parts of people's and animals' bodies
EP0789031A3 (pt)
Willatts Addition to the Catalogue of Early Iron Graveslabs in the Weald1
Cheng Television in the People's Republic of China: social analysis and projection
IT1225776B (it) Attacco dentale intra-extracoronale con regolazione ad angolo

Legal Events

Date Code Title Description
FA Application withdrawn